- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00581347
Primary Care and Adolescent Immunization for Rochester (PCAIR)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Outreach workers will be placed at 9 primary care pediatric and family medicine practices throughout one urban area. Adolescent patients at these 9 practices will be identified and then randomized into two groups; (1) those receiving outreach intervention during Year 1 of the study and (2) those receiving outreach intervention during Year 2 of the study. Randomization will be stratified by practice site, patient age, and patient gender.
After randomization, the list of Year 1 subjects will be distributed to the appropriate outreach worker. The outreach worker will track the immunization status of 11-15yo patients within their practice, identify patients who are eligible for but have not yet received immunizations recommended for their age group (MMR, Varicella, Hepatitis B, HPV, Meningococcal Conjugate, Tdap) and/or a well child visit within the past year, and then attempt to connect these patients with medical care through three levels of outreach activity. First level of outreach activity involves contacting the parent/guardian of the patient by telephone. Outreach workers will attempt to inform patient's parent/guardian of needed immunizations/preventive visit and facilitate the scheduling of a medical appointment. If unable to successfully complete the task through telephone contact, outreach workers will initiate the second level of outreach activity - contact by mail. If contact by mail is unsuccessful, the third and most intense level of outreach activity will be implemented. The outreach worker will attempt to notify the patient's parent/guardian of need for immunization/preventive appointment by visiting the patient's listed home address. During this visit, the outreach worker will attempt to inform the parent/guardian of recommended immunizations, provide information pertaining to these immunizations, facilitate appointment scheduling, and assist patient in compliance with scheduled medical appointment
Interventions directed towards the subjects of the Year 1 group will cease after 15 months of outreach activity. A chart review of intervention and control groups will be conducted to determine immunization and well child visit rates within the two groups. At this time, the tracking/reminder/recall/home visiting strategy employed with the Year 1 group will be repeated for Year 2 subjects.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 11-15 years of age
- receive medical care at one of the 9 pediatric or family medicine practices identified as study sites
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Outreach
Receives outreach services
|
Tracking/reminder/recall/home visit strategy.
|
No Intervention: Standard of Care
Receives standard medical care provided by primary care practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Receipt of Adolescent Immunization at End of Study Period (Tdap, Menactra, HPV)
Time Frame: 15 months
|
We compared the number of participants in the intervention group who received vaccinations for Tdap, Menactra, and (for girls only) HPV at the end of the study period versus those in the control group.
|
15 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Receipt of a Well Child Visit Within a 12 Month Period
Time Frame: 1 year
|
We compared the number of participants in the intervention group who received a well child visit within a 12 month period versus those in the control group.
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Peter Szilagyi, MD, University of Rochester
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PCAIR
- OPP-P-2006-24
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preventive Care
-
Qure Healthcare, LLCApplied Proteomics IncCompleted
-
Unity Health TorontoCompletedPreventive Health CareCanada
-
Boston Medical CenterAgency for Healthcare Research and Quality (AHRQ)CompletedPreventive Care | Medication ManagementUnited States
-
Agency for Healthcare Research and Quality (AHRQ)UnknownWell Child Preventive CareUnited States
-
María José del Olmo RubioHospital Universitario 12 de OctubreCompleted
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingContraception | Breastfeeding | Preventive Care / Anticipatory Guidance | Retention in Care | Postpartum HealthUnited States
-
Pontificia Universidad Catolica de ChileFundacion MAPFRE; Fundacion Hispanoamericana de SolidaridadCompletedPreventive Medicine | Family | Family Practice | Adolescent Health Services | Primary Heath CareChile
-
Arjo FrancePôle Saint HélierRecruiting
-
University of TabukCompletedDiabetes Mellitus, Type 2 | Preventive Care | Self-careSaudi Arabia
-
Tel Hai CollegeRecruitingPreventive TherapyIsrael
Clinical Trials on outreach services
-
University of Texas Southwestern Medical CenterMichael E. DeBakey VA Medical Center; Parkland Health and Hospital SystemCompletedCarcinoma, Hepatocellular | Liver NeoplasmsUnited States
-
US Department of Veterans AffairsCompleted
-
University of RochesterMonroe County Department of Human Services; United Way of Greater RochesterCompleted
-
University of PennsylvaniaCompletedCancer of the Colon
-
Harvard Medical School (HMS and HSDM)Humana Co.Ltd.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Kaiser PermanenteCompleted
-
Massachusetts General HospitalNot yet recruitingFood Insecurity | Nutrition, Healthy | Vulnerable Populations
-
University of Sao Paulo General HospitalUniversity of Sao Paulo; University of East Anglia; University of Cape Town; Medical... and other collaboratorsUnknownHeart Failure | Hypertension | Diabetes Mellitus | Ischemic Heart Disease | Cerebrovascular DiseaseBrazil
-
Kaiser PermanenteCompleted
-
University of Sao Paulo General HospitalUniversity of Sao Paulo; University of East Anglia; University of Cape Town; Medical... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease | AsthmaBrazil